Bionow | News

Lung cancer study offers further evidence on importance of screening

Jun 5th 2024

Researchers from the University of Liverpool and Queen Mary University of London have published the first study in the UK to demonstrate the benefits of lung cancer screening across socioeco...

ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers...

May 7th 2024

The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for its fl...

Major funding extension to advance revolutionary long-acting therapeutic technol...

Apr 22nd 2024

Unitaid has awarded more than £6M of new funding to a University of Liverpool-led project aiming to improve the long-acting therapeutics available to treat or prevent tuberculosis, malaria ...

World Alzheimer's Day- using AI to diagnose early stages of the disease

Sep 21st 2023

Stopping memory loss: how to use AI to diagnose and treat dementia early.

University secures £2.66m to develop personalised cancer treatment

Sep 15th 2023

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership

Jul 29th 2021

Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit.

Watch Dr Derek Ogg Discuss G6b-B – a Unique Platelet Receptor

Feb 15th 2021

Peak Proteins was asked to determine the X-ray structure of the relatively small G6b-B ectodomain bound to a recombinant Fab fragment that they had discovered in order to identify its bindin...

Mapping COVID-19 through whole genome sequencing

Oct 21st 2020

A team from the University of Liverpool is part of a UK genomic sequencing alliance to map how COVID-19 spreads and behaves.

Arcis Biotechnology appoints Professor Steve Howell as Non-Executive Chairman

Jul 31st 2019

Arcis Biotechnology, the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve...

University of Liverpool invests in `Porous Liquid Technologies Ltd', a joint ven...

Oct 16th 2018

The University of Liverpool and Queen’s University Belfast are participating in a joint-venture spin-out company to take forward a new class of materials known as porous liquids, invented ...

Glythera appoints Professor Kerry Chester to SAB

Apr 30th 2018

Glythera Limited (Glythera), the next-generation antibody drug conjugate (ADC) development company, today announces that it has appointed Professor Kerry Chester to its Scientific Advisory B...

Manchester Imaging Raises £600k to Launch Dental Diagnostic Software

Feb 1st 2018

Manchester Imaging, a dental diagnostic software company, today announced that it has raised a £600,000 investment from the GM&C Life Sciences Fund, managed by Catapult Ventures, and NPIF -...

News